2/6 The DEEPER LIMUS study focused on patients with Rutherford class 3 to 5 infrapopliteal artery disease. Participants underwent vessel preparation with retrievable scaffold therapy followed by sirolimus-coated balloon angioplasty 💉 #InterventionalRadiology #VascularSurgery

3/6 Results at 6 months: 🔹 11.5% primary safety events (1 mortality, 1 major amputation, 1 target lesion revascularization) 🔹 Late lumen loss: 0.7±0.7 mm 🔹 Negligible acute vessel recoil (2.4 mm to 2.3 mm)

4/6 By 12 months: 📈 89.5% primary patency ✅ 68.2% improved Rutherford class 🦶 90% low/very low amputation risk (WIfI scores) ✨ No additional major amputations or target lesion revascularizations #VascularHealth #PatientOutcomes

5/6 📌 Conclusion: This study demonstrates high 12-month primary patency (89.5%) and low complication rates using retrievable scaffold therapy with sirolimus-coated balloon angioplasty for infrapopliteal lesions. Read more here:

6/6 What are your thoughts? IRs using #AI will replace those who don’t! Save time, get smarter, & become AI enhanced! Be sure to subscribe our newsletter: https://t.co/xvxop1PZ7C Follow us on LinkedIn: https://t.co/r90x5SiAjj #VIR #iRads @CVIR_Journal @cvirendo @cirsesociety